Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (U01DK127429)
Article History
Received: 13 February 2023
Accepted: 24 May 2023
First Online: 2 June 2023
Competing interests
: J.E.T. is a scientific advisor for Prolific Machines and Nereid Therapeutics. H.M.M. is a cofounder and scientific advisor for C16 Biosciences. The remaining authors declare no competing interests.